What does CUSIP 76029N106 represent in this 13F holders report?

CUSIP 76029N106 is the security identifier for REPL - Replimune Group, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held REPL - Replimune Group, Inc. - COMMON STOCK in Q2 2022?

98 institutional investors reported REPL - Replimune Group, Inc. - COMMON STOCK for Q2 2022. Use the holders table for investor-level position and value details.

Replimune Group, Inc. - COMMON STOCK (REPL)

CUSIP: 76029N106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COMMON STOCK
Shares outstanding: 80,239,086
Total 13F shares: 39,999,317
Share change: +1,007,569
Total reported value: $700,208,199
Price per share: $17.48
Number of holders: 98
Value change: +$17,983,844
Number of buys: 38
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 76029N106?
CUSIP 76029N106 identifies REPL - Replimune Group, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 76029N106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of REPL - Replimune Group, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Omega Fund IV, L.P.	3/4/5	10%+ Owner	— mixed-class rows	9,453,260 mixed-class rows	$103,049,420	—	14 Mar 2022	3/4/5
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	7.5%	6,022,760	$102,266,000	—	31 Mar 2022	13F
Omega Fund Management, LLC	13F	Company	5.8%	4,673,380	$79,354,000	—	31 Mar 2022	13F
Redmile Group, LLC	13F	Company	4.6%	3,691,312	$62,678,000	—	31 Mar 2022	13F
Atlas Venture Life Science Advisors, LLC	13F	Company	4%	3,209,627	$54,499,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	2.7%	2,135,754	$36,264,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	2.1%	1,712,037	$29,070,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	2%	1,625,758	$27,606,000	—	31 Mar 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	2%	1,611,703	$27,367,000	—	31 Mar 2022	13F
EMERALD ADVISERS, LLC	13F	Company	1.4%	1,134,012	$19,256,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	1.3%	1,080,815	$18,352,000	—	31 Mar 2022	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	1.2%	986,270	$16,747,000	—	31 Mar 2022	13F
BVF INC/IL	13F	Company	1.2%	926,529	$15,732,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	1.1%	900,000	$15,282,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	854,800	$14,515,000	—	31 Mar 2022	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.89%	716,762	$12,171,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.75%	601,445	$10,212,536	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.73%	586,838	$9,965,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.68%	542,299	$9,208,000	—	31 Mar 2022	13F
S.c.a. Candriam	13F	Individual	0.61%	492,504	$8,363,000	—	31 Mar 2022	13F
Amundi	13F	Individual	0.39%	316,854	$6,271,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.43%	344,397	$5,848,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.42%	338,055	$5,740,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.38%	301,816	$5,125,000	—	31 Mar 2022	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.32%	260,249	$4,424,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.27%	218,792	$3,715,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.27%	215,847	$3,666,000	—	31 Mar 2022	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.27%	212,640	$3,611,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.26%	211,053	$3,584,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.24%	194,900	$3,309,000	—	31 Mar 2022	13F
Integral Health Asset Management, LLC	13F	Company	0.21%	165,000	$2,802,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.2%	158,526	$2,691,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	141,577	$2,403,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.17%	138,720	$2,355,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.17%	137,367	$2,332,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.16%	127,321	$2,162,000	—	31 Mar 2022	13F
TD ASSET MANAGEMENT INC	13F	Company	0.15%	117,523	$1,996,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.14%	109,076	$1,853,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	111,519	$1,760,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.13%	100,431	$1,705,000	—	31 Mar 2022	13F
OSTERWEIS CAPITAL MANAGEMENT INC	13F	Company	0.12%	99,145	$1,683,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.12%	94,433	$1,603,000	—	31 Mar 2022	13F
SG Americas Securities, LLC	13F	Company	0.11%	91,479	$1,553,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.11%	87,124	$1,479,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.1%	78,733	$1,337,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.1%	78,543	$1,334,969	—	31 Mar 2022	13F
Nan Fung Group Holdings Ltd	13F	Company	0.09%	74,479	$1,265,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	72,578	$1,233,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.06%	49,900	$847,000	—	31 Mar 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.06%	49,090	$834,000	—	31 Mar 2022	13F

Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2022

As of 30 Jun 2022, Replimune Group, Inc. - COMMON STOCK (REPL) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,999,317 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Omega Fund Management, LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, Atlas Venture Life Science Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, EMERALD ADVISERS, LLC, and FMR LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

104

Q2 2022 holders

Holder diff

-6

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.